<!DOCTYPE html>
<!--
    Type on Strap jekyll theme v2.4.12
    Theme free for personal and commercial use under the MIT license
    https://github.com/sylhare/Type-on-Strap/blob/master/LICENSE
-->
<html lang="en">
  
  <head> <meta charset="utf-8"> <meta name="viewport" content="width=device-width, initial-scale=1, minimum-scale=0.5, maximum-scale=5"> <!-- Theme Mode--> <script> const darkBtn = "Dark"; const lightBtn = "Light"; const isAutoTheme = false; const preferredTheme = window.matchMedia('(prefers-color-scheme: dark)').matches ? 'dark' : 'light'; if (isAutoTheme) { document.documentElement.setAttribute('data-theme', sessionStorage.getItem('theme') ?? preferredTheme); } else { document.documentElement.setAttribute('data-theme', "light"); } </script> <!-- Main JS (navbar.js, katex_init.js and masonry_init.js)--> <script defer src="/pages/prin-tempo/assets/js/main.min.js"></script> <!-- CSS --> <link rel="stylesheet" href="/pages/prin-tempo/assets/css/main.css"> <!--Favicon--> <link rel="shortcut icon" href="" type="image/x-icon"> <!-- KaTeX 0.16.11 --> <!-- Mermaid 11.4.1 --> <!-- Simple Jekyll Search 1.10.0 --> <script src="/pages/prin-tempo/assets/js/vendor/simple-jekyll-search.min.js" type="text/javascript"></script> <!-- Google Analytics / Cookie Consent --> <script> const cookieName = 'cookie-notice-dismissed-https://prin-tempo.github.io'; const isCookieConsent = ''; const analyticsName = ''; const analyticsNameGA4 = ''; </script> <!-- seo tags --> <meta property="og:image" content="https://prin-tempo.github.io/pages/prin-tempo/assets/images/logo_tempo.png"> <meta property="og:type" content="website" /> <!-- Begin Jekyll SEO tag v2.8.0 --> <title>About | TEMPO Project</title> <meta name="generator" content="Jekyll v3.10.0" /> <meta property="og:title" content="About" /> <meta property="og:locale" content="en_US" /> <meta name="description" content="Il progetto “Tight control of treatment efficacy with tElemedicine for an improved Management of Patients with hemOphilia” (TEMPO) si occupa di ideare e sviluppare soluzioni avanzate di telemedicina per il monitoraggio dei pazienti affetti da emofilia." /> <meta property="og:description" content="Il progetto “Tight control of treatment efficacy with tElemedicine for an improved Management of Patients with hemOphilia” (TEMPO) si occupa di ideare e sviluppare soluzioni avanzate di telemedicina per il monitoraggio dei pazienti affetti da emofilia." /> <link rel="canonical" href="https://prin-tempo.github.io/pages/prin-tempo/about/" /> <meta property="og:url" content="https://prin-tempo.github.io/pages/prin-tempo/about/" /> <meta property="og:site_name" content="TEMPO Project" /> <meta property="og:type" content="website" /> <meta name="twitter:card" content="summary" /> <meta property="twitter:title" content="About" /> <script type="application/ld+json"> {"@context":"https://schema.org","@type":"WebSite","description":"Il progetto “Tight control of treatment efficacy with tElemedicine for an improved Management of Patients with hemOphilia” (TEMPO) si occupa di ideare e sviluppare soluzioni avanzate di telemedicina per il monitoraggio dei pazienti affetti da emofilia.","headline":"About","name":"TEMPO Project","url":"https://prin-tempo.github.io/pages/prin-tempo/about/"}</script> <!-- End Jekyll SEO tag --> <!-- RSS --> <link rel="alternate" type="application/atom+xml" title="TEMPO Project" href="https://prin-tempo.github.io/pages/prin-tempo/feed.xml"/> <link type="application/atom+xml" rel="alternate" href="https://prin-tempo.github.io/pages/prin-tempo/feed.xml" title="TEMPO Project" /> <!-- Twitter Cards --> <meta name="twitter:title" content="About"> <meta name="twitter:description" content="Hemophilia A and B are rare bleeding disorders due to coagulation factor VIII (FVIII) and FIX deficiency, respectively. Repeated jointbleeding (hemarthrosis)..."> <meta name="twitter:card" content="summary"> <meta name="twitter:image" content="https://prin-tempo.github.io/pages/prin-tempo/assets/images/logo_tempo.png"> <meta name="twitter:image:alt" content="About"> </head>
  <body>
    
    <header class="site-header"> <!-- Logo and title --> <div class="branding"> <a class="site-title" aria-label="TEMPO Project" href="/pages/prin-tempo/"> TEMPO Project </a> </div> <!-- Toggle menu --> <nav class="clear"> <a aria-label="pull" id="pull" class="toggle" href="#"> <i class="fas fa-bars fa-lg"></i> </a> <!-- Menu --> <ul class="hide"> <li class="separator"> | </li> <li> <a class="clear" aria-label="About" title="About" href="/pages/prin-tempo/about/"> <span class="navbar-label ">About</span> </a> </li> <li class="separator"> | </li> <li> <a class="clear" aria-label="Consortium" title="Consortium" href="/pages/prin-tempo/consortium/"> <span class="navbar-label ">Consortium</span> </a> </li> <li class="separator"> | </li> <li> <a class="clear" aria-label="News" title="News" href="/pages/prin-tempo/news/"> <span class="navbar-label ">News</span> </a> </li> <li class="separator"> | </li> <li> <a class="clear" aria-label="Media & Publications" title="Media & Publications" href="/pages/prin-tempo/dissemination/"> <span class="navbar-label ">Media & Publications</span> </a> </li> </ul> </nav> </header>
    <div class="content">
      <article >
    <header id="main" style="background-image: url('')">
        <div class="title-padder">
            
                <h1 id="About" class="title"> About</h1>
                
            
        </div>
    </header>
    <section class="post-content">
    
            <p>Hemophilia A and B are rare bleeding disorders due to coagulation factor VIII (FVIII) and FIX deficiency, respectively. Repeated joint<br />
bleeding (hemarthrosis) leads to chronic arthropathy, disability, and early prosthetic surgery. Indeed, bleeding can be prevented by<br />
regular prophylactic treatment, although adherence is often suboptimal, in particular in young adults. Annual bleeding rate (ABR)<br />
has been traditionally used as an outcome measure of treatment efficacy, although it is a patient-reported outcome and there is<br />
evidence that patients often report as bleeding events also joint pain episodes due to chronic arthropathy. In addition, bleeding may<br />
even occur in asymptomatic joints. Therefore, a definite diagnosis of hemarthrosis is pivotal and a personalized management is<br />
warranted to avoid overtreatment or undertreatment. To date, a definite diagnosis of hemarthrosis can be confirmed by ultrasound<br />
or arthrocentesis at the Hemophilia Treatment Center (HTC).</p>

<p>The World Federation of Hemophilia acknowledges the importance of software-based diaries for treatment adherence and<br />
communication with the HTC. Electronic diaries may increase the quantity of information provided by the patients, while improving<br />
the data quality. The huge amount of data collected, properly integrated and made available through analytical and visual<br />
dashboards, may support clinicians in personalizing treatment.</p>

<p>On this background, we will develop a home-based integrated system for patient adherence to treatment by active assistance with<br />
reminders and collection of data on spontaneous and post-traumatic bleeding events, quality of life, productivity and pain through<br />
the use of a mobile application and wearable sensors to monitor physical activity. In a subgroup of patients, an exploratory study will<br />
be conducted with a portable wireless ultrasound probe compatible with smartphones and tablets. A user-friendly mobile app will<br />
guide the patient in the collection of images that will be transferred to the HTC. A computer-assisted diagnosis (CAD) tool prototyped<br />
by our research team will support physicians in providing the patient a quick response. Aim of the TEMPO study is to investigate the<br />
feasibility, acceptability and sustainability of such telemedicine system and to evaluate its efficacy in improving adherence to<br />
treatment; to explore the feasibility of integrating patient-based joint ultrasound assessment; and to pave the way for a personalized<br />
management in contrast with a “one-size-fits all” model. The ultimate goal is to improve patients’ quality of life, while also reducing<br />
disease burden. Moreover, we will explore beyond state of the art approaches to further improve the efficacy of at home sensors and<br />
devices in tackling spontaneous or traumatic bleeding.</p>

            
    </section>
    <!-- Tag list for portfolio -->
    
    
    <div class="tag-list"></div>
</article>

    </div>
    
    <footer class="site-footer"> <p class="text"> This project has received funding from the European Union’s "Next Generation EU" research and innovation programme under CUP G53D23005190006.</p> <div class="footer-icons"> <ul> <!-- Social icons from Font Awesome, if enabled --> </ul> </div> </footer>
  </body>
</html>
